
    
      In this study, the reliability and validity of FIBSER Scale, Doctor-patient Relationship
      Scale-Patient Edition (STAR-P) and HEA in Chinese population will be verified to increase the
      diversity and selectivity of domestic assessment tools.

      This study includes two steps.

        1. baseline: demographic data, HAM-D, HAM-A, YMRS, drug side effects scale：FIBSER, TESS；
           doctor-patient relationship scale ：STAR-P, PDRQ-15；Health economics follow-up evaluation
           scale ：SDS and HEA were evaluated.

        2. follow-up (4 weeks): HAM-D, HAM-A, YMRS, FIBSER, STAR-P and HEA scale in order to verify
           the reliability of retest.
    
  